Carregant...
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer
SIMPLE SUMMARY: Two-thirds of breast cancer patients present an estrogen receptor–positive tumor at diagnosis, and the main treatment options for these patients are endocrine therapies such as aromatase inhibitors, selective modulators of estrogen receptor activity or selective estrogen receptor dow...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7962645/ https://ncbi.nlm.nih.gov/pubmed/33800302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13051160 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|